was read the article
array:24 [ "pii" => "S0300289616301764" "issn" => "03002896" "doi" => "10.1016/j.arbres.2016.05.020" "estado" => "S300" "fechaPublicacion" => "2016-10-01" "aid" => "1405" "copyright" => "SEPAR" "copyrightAnyo" => "2016" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:541" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2644 "formatos" => array:3 [ "EPUB" => 111 "HTML" => 1886 "PDF" => 647 ] ] "Traduccion" => array:1 [ "en" => array:19 [ "pii" => "S1579212916301847" "issn" => "15792129" "doi" => "10.1016/j.arbr.2016.07.026" "estado" => "S300" "fechaPublicacion" => "2016-10-01" "aid" => "1405" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:541" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1774 "formatos" => array:3 [ "EPUB" => 115 "HTML" => 1155 "PDF" => 504 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Letter to the Editor</span>" "titulo" => "Eosinophils and Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "541" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Eosinófilos y corticoides inhalados en la enfermedad pulmonar obstructiva crónica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Adolfo Baloira Villar, Abel Pallarés Sanmartín, Marta Núñez Fernández" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Adolfo Baloira" "apellidos" => "Villar" ] 1 => array:2 [ "nombre" => "Abel Pallarés" "apellidos" => "Sanmartín" ] 2 => array:2 [ "nombre" => "Marta Núñez" "apellidos" => "Fernández" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289616301764" "doi" => "10.1016/j.arbres.2016.05.020" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616301764?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916301847?idApp=UINPBA00003Z" "url" => "/15792129/0000005200000010/v2_201609300109/S1579212916301847/v2_201609300109/en/main.assets" ] ] "itemAnterior" => array:19 [ "pii" => "S0300289616301296" "issn" => "03002896" "doi" => "10.1016/j.arbres.2016.04.014" "estado" => "S300" "fechaPublicacion" => "2016-10-01" "aid" => "1390" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:540" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4085 "formatos" => array:3 [ "EPUB" => 109 "HTML" => 3182 "PDF" => 794 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Corticoides inhalados, eosinófilos y exacerbaciones de la enfermedad pulmonar obstructiva crónica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "540" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Inhaled corticosteroids, eosinophils and chronic obstructive pulmonary disease exacerbations" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rafael Golpe, Irene Martín-Robles, Pilar Sanjuán-López" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Rafael" "apellidos" => "Golpe" ] 1 => array:2 [ "nombre" => "Irene" "apellidos" => "Martín-Robles" ] 2 => array:2 [ "nombre" => "Pilar" "apellidos" => "Sanjuán-López" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212916301707" "doi" => "10.1016/j.arbr.2016.04.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916301707?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616301296?idApp=UINPBA00003Z" "url" => "/03002896/0000005200000010/v3_201609300128/S0300289616301296/v3_201609300128/es/main.assets" ] "asociados" => array:1 [ 0 => array:19 [ "pii" => "S0300289616301296" "issn" => "03002896" "doi" => "10.1016/j.arbres.2016.04.014" "estado" => "S300" "fechaPublicacion" => "2016-10-01" "aid" => "1390" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Arch Bronconeumol. 2016;52:540" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4085 "formatos" => array:3 [ "EPUB" => 109 "HTML" => 3182 "PDF" => 794 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Corticoides inhalados, eosinófilos y exacerbaciones de la enfermedad pulmonar obstructiva crónica" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "540" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Inhaled corticosteroids, eosinophils and chronic obstructive pulmonary disease exacerbations" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Rafael Golpe, Irene Martín-Robles, Pilar Sanjuán-López" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Rafael" "apellidos" => "Golpe" ] 1 => array:2 [ "nombre" => "Irene" "apellidos" => "Martín-Robles" ] 2 => array:2 [ "nombre" => "Pilar" "apellidos" => "Sanjuán-López" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212916301707" "doi" => "10.1016/j.arbr.2016.04.007" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212916301707?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616301296?idApp=UINPBA00003Z" "url" => "/03002896/0000005200000010/v3_201609300128/S0300289616301296/v3_201609300128/es/main.assets" ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta al Director</span>" "titulo" => "Eosinófilos y corticoides inhalados en la enfermedad pulmonar obstructiva crónica" "tieneTextoCompleto" => true "saludo" => "<span class="elsevierStyleItalic">Sr. Director:</span>" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "541" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Adolfo Baloira Villar, Abel Pallarés Sanmartín, Marta Núñez Fernández" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Adolfo" "apellidos" => "Baloira Villar" "email" => array:1 [ 0 => "adolfo.baloira.villar@sergas.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Abel" "apellidos" => "Pallarés Sanmartín" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Marta" "apellidos" => "Núñez Fernández" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Servicio de Neumología, Complejo Hospitalario Universitario de Pontevedra, Casas Novas, Pontevedra, España" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Álvaro Cunqueiro, Vigo, Pontevedra, España" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Autor para correspondencia." ] ] ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Eosinophils and Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Agradecemos los comentarios recibidos, con los que en esencia estamos de acuerdo<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a>. Existen todavía importantes puntos por aclarar respecto al papel que la eosinofilia sanguínea juega en el manejo de la enfermedad pulmonar obstructiva crónica (EPOC), quizá el más importante el número absoluto o relativo de eosinófilos que tiene un valor diferencial, ya sea pronóstico, terapéutico o incluso para definir lo que podría ser un fenotipo propio. Como señalan los autores, los estudios realizados son en su mayor parte análisis <span class="elsevierStyleItalic">post hoc</span>, pero también es cierto que en todos ellos los resultados son coincidentes: la respuesta a los corticoides inhalados es solo significativa a partir de un valor determinado de eosinófilos sanguíneos: Desde que escribimos nuestra carta, hace algo más de un año, se han publicado nuevos estudios que añaden más evidencia a esta conclusión. Un reanálisis de ISOLDE mostró una reducción de la pérdida de FEV1 de unos 34<span class="elsevierStyleHsp" style=""></span>ml/año en los pacientes con más del 2% de eosinófilos en el momento de inicio del estudio, mientras que por debajo de este valor no hubo diferencias<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a>. Otra forma de enfocar esta cuestión se ha realizado con un nuevo análisis del estudio WISDOM, donde tras la retirada de fluticasona se observó un incremento de agudizaciones, únicamente cuando el porcentaje de eosinófilos era igual o superior al 2%, con un riesgo relativo (RR) de 1,22, aumentando a medida que lo hacía la eosinofilia (≥<span class="elsevierStyleHsp" style=""></span>4%, RR: 1,63; ≥<span class="elsevierStyleHsp" style=""></span>5%, RR: 1,82)<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a>.</p><p id="par0010" class="elsevierStylePara elsevierViewall">En resumen, aun coincidiendo con los autores en la mayor parte de sus aseveraciones, creemos que las evidencias disponibles hacen de los eosinófilos sanguíneos un excelente biomarcador de respuesta a corticoides inhalados en la EPOC, e incluso podrían conformar un fenotipo específico<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a>.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Bibliografía" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Corticoides inhalados, eosinófilos y exacerbaciones de enfermedad pulmonar obstructiva crónica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Golpe" 1 => "I. Martín-Robles" 2 => "P. Sanjuán-López" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2015.06.004" "Revista" => array:5 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2016" "volumen" => "52" "paginaInicial" => "229" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26216714" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood eosinophils as a marker of response to inhaled corticosteroids in COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "N.C. Barnes" 1 => "R. Sharma" 2 => "S. Lettis" 3 => "P.M. Calverley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/13993003.01370-2015" "Revista" => array:6 [ "tituloSerie" => "Eur Respir J" "fecha" => "2016" "volumen" => "47" "paginaInicial" => "1374" "paginaFinal" => "1382" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26917606" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: A post-hoc analysis of the WISDOM trial" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Watz" 1 => "K. Tetzlaff" 2 => "E.F. Wouters" 3 => "A. Kirsten" 4 => "H. Magnussen" 5 => "R. Rodríguez-Roisin" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(13)70187-5" "Revista" => array:4 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2016" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24429275" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0140673601057750" "estado" => "S300" "issn" => "01406736" ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Enfermedad pulmonar obstructiva crónica con eosinofilia, ¿un fenotipo emergente?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Baloira Villar" 1 => "A. Pallarés Sanmartín" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2015.11.015" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2016" "volumen" => "52" "paginaInicial" => "177" "paginaFinal" => "178" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26852358" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "es" "url" => "/03002896/0000005200000010/v3_201609300128/S0300289616301764/v3_201609300128/es/main.assets" "Apartado" => array:4 [ "identificador" => "9222" "tipo" => "SECCION" "es" => array:2 [ "titulo" => "Letters to the Director / Cartas al Director" "idiomaDefecto" => true ] "idiomaDefecto" => "es" ] "PDF" => "https://static.elsevier.es/multimedia/03002896/0000005200000010/v3_201609300128/S0300289616301764/v3_201609300128/es/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289616301764?idApp=UINPBA00003Z" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 10 | 3 | 13 |
2024 October | 88 | 15 | 103 |
2024 September | 78 | 14 | 92 |
2024 August | 87 | 36 | 123 |
2024 July | 61 | 21 | 82 |
2024 June | 99 | 24 | 123 |
2024 May | 90 | 28 | 118 |
2024 April | 71 | 30 | 101 |
2024 March | 57 | 22 | 79 |
2024 February | 40 | 37 | 77 |
2023 March | 8 | 3 | 11 |
2023 February | 69 | 18 | 87 |
2023 January | 48 | 31 | 79 |
2022 December | 74 | 29 | 103 |
2022 November | 120 | 32 | 152 |
2022 October | 95 | 34 | 129 |
2022 September | 86 | 22 | 108 |
2022 August | 87 | 36 | 123 |
2022 July | 60 | 39 | 99 |
2022 June | 72 | 33 | 105 |
2022 May | 77 | 36 | 113 |
2022 April | 100 | 31 | 131 |
2022 March | 95 | 39 | 134 |
2022 February | 94 | 27 | 121 |
2022 January | 88 | 32 | 120 |
2021 December | 57 | 37 | 94 |
2021 November | 68 | 49 | 117 |
2021 October | 68 | 47 | 115 |
2021 September | 63 | 50 | 113 |
2021 August | 51 | 47 | 98 |
2021 July | 63 | 34 | 97 |
2021 June | 83 | 52 | 135 |
2021 May | 61 | 38 | 99 |
2021 April | 146 | 97 | 243 |
2021 March | 96 | 41 | 137 |
2021 February | 87 | 34 | 121 |
2021 January | 53 | 26 | 79 |
2020 December | 71 | 46 | 117 |
2020 November | 93 | 40 | 133 |
2020 October | 62 | 26 | 88 |
2020 September | 59 | 33 | 92 |
2020 August | 60 | 23 | 83 |
2020 July | 67 | 25 | 92 |
2020 June | 67 | 11 | 78 |
2020 May | 57 | 26 | 83 |
2020 April | 52 | 19 | 71 |
2020 March | 72 | 27 | 99 |
2020 February | 57 | 22 | 79 |
2020 January | 85 | 15 | 100 |
2019 December | 79 | 26 | 105 |
2019 November | 38 | 25 | 63 |
2019 October | 52 | 22 | 74 |
2019 September | 56 | 14 | 70 |
2019 August | 42 | 15 | 57 |
2019 July | 29 | 16 | 45 |
2019 June | 31 | 15 | 46 |
2019 May | 63 | 18 | 81 |
2019 April | 68 | 24 | 92 |
2019 March | 37 | 21 | 58 |
2019 February | 38 | 28 | 66 |
2019 January | 35 | 24 | 59 |
2018 December | 45 | 21 | 66 |
2018 November | 79 | 25 | 104 |
2018 October | 120 | 21 | 141 |
2018 September | 50 | 17 | 67 |
2018 August | 1 | 0 | 1 |
2018 May | 48 | 1 | 49 |
2018 April | 68 | 9 | 77 |
2018 March | 72 | 10 | 82 |
2018 February | 89 | 14 | 103 |
2018 January | 102 | 14 | 116 |
2017 December | 83 | 10 | 93 |
2017 November | 33 | 7 | 40 |
2017 October | 29 | 12 | 41 |
2017 September | 23 | 11 | 34 |
2017 August | 40 | 20 | 60 |
2017 July | 30 | 12 | 42 |
2017 June | 45 | 28 | 73 |
2017 May | 43 | 18 | 61 |
2017 April | 50 | 20 | 70 |
2017 March | 30 | 12 | 42 |
2017 February | 28 | 19 | 47 |
2017 January | 30 | 15 | 45 |
2016 December | 1 | 4 | 5 |
2016 November | 6 | 3 | 9 |
2016 October | 31 | 26 | 57 |
2016 September | 10 | 8 | 18 |
2016 August | 4 | 5 | 9 |
2016 July | 8 | 9 | 17 |